Mechanisms of change in thoracic duct lymph flow during hypotensive states.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D002199:Capillary Permeability; D002319:Cardiovascular System / Q000187:drug effects; D002395:Catecholamines / Q000494:pharmacology; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007022:Hypotension / Q000503:physiopathology*; D007545:Isoproterenol / Q000494:pharmacology; D008208:Lymphatic System / Q000187:drug effects; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012769:Shock / Q000503:physiopathology*; D012771:Shock, Hemorrhagic / Q000503:physiopathology; D012772:Shock, Septic / Q000503:physiopathology; D013897:Thoracic Duct / Q000187:drug effects / Q000503:physiopathology*; D014690:Venous Pressure / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D010643:Phenoxybenzamine; D011433:Propranolol; D011398:Promethazine; D007545:Isoproterenol; D001241:Aspirin; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine